poisar

Stocks · News reference

Guardant Health Introduces New Epigenomic Applications for Guardant360® Liquid

Fiscal.ai

Guardant Health has launched new epigenomic applications for its Guardant360® Liquid test, providing oncologists with enhanced insights for treatment selection in patients lacking traditional biomarkers.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Guardant Health, Inc. (GH)

    Filed: 2026-11-16 AccNo: 0001193125-26-463573 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits